Funder: American Cancer Society
Due Dates: June 1, 2026 | December 1, 2026 | June 1, 2025 | December 1, 2025
Funding Amounts: Stage I: up to $135,000/year direct costs + 10% indirect (max $297,000 over 2 years); Stage II: up to $545,000 direct costs + 10% indirect (max 18 months)
Summary: Supports innovative cancer research projects that translate scientific discoveries into human testing, with staged funding for clinical-enabling studies.
Key Information: Applicants may submit only one MBG I or II per cycle and may not submit RSG, DBG, or CSDG in the same cycle.